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Abstract
Transfer of terminal K2,6-linked sialic acids to N-glycans is catalyzed by L-galactoside K2,6-sialyltransferase (ST6Gal I).
Expression of ST6Gal I and its products is reportedly increased in colon cancers. To investigate directly the functional effects
of ST6Gal I expression, human colon cancer (HT29) cells were transfected with specific antisense DNA. ST6Gal I mRNA
and protein were virtually undetectable in six strains of transfected HT29 cells. ST6Gal activity was reduced to 14% of
control (P6 0.005) in transfected cells. Expression of terminal K2,6- and K2,3-linked sialic acids, and unmasked N-
acetyllactosamine oligosaccharides, respectively, was assessed using flow cytometry and fluoresceinated Sambucus nigra,
Maackia amurensis and Erythrina cristagalli lectins. Results indicated a major reduction in expression of K2,6-linked sialic
acids and counterbalancing increase in unmasked N-acetyllactosamines in antisense DNA-transfected cells, without altered
expression of K2,3-linked sialic acids or ganglioside profiles. The ability of transfected cells to form colonies in soft agar and
to invade extracellular matrix material (Matrigel), respectively, in vitro was reduced by approx. 98% (P6 0.0001) and more
than 3-fold (P6 0.005) compared to parental HT29 cells. These results indicate that N-glycans bearing terminal K2,6-linked
sialic acids may enhance the invasive potential of colon cancer cells. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Oligosaccharide units of glycoconjugates ful¢ll
many cellular recognition and modulatory functions
[1]. Because of their charge and terminal position a
prominent contribution to oligosaccharide function
has long been predicted or claimed for sialic acids.
Three sialic acid (sia) linkages exist in mammalian
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glycoconjugates, K2-3 (ST3), K2-6 (ST6) and K2-8
(ST8), of which the ST8 linkage is least and the
ST3 linkage is most abundant [2]. Though less abun-
dant than K2-3 linked sialic acid, the K2-6 linked
variety is widely expressed in adult mammalian tis-
sues.
Each sugar of an oligosaccharide is added by a
glycosyltransferase that is speci¢c for donor and ac-
ceptor sugars and the anomeric linkage [3]. Glycosyl-
transferases that synthesize the same linkage are dis-
tinguishable by di¡erential speci¢city for
glycoprotein or glycolipid acceptor, di¡erent patterns
of tissue distribution or other characteristics. The
sialyltransferases are glycosyltransferases that trans-
fer sialic acids to oligosaccharides. More than 10
mammalian sialyltransferases have been identi¢ed
for synthesis of ST3 and ST6 linkages in serine/threo-
nine (O)- and asparagine (N)-linked glycans [2,4].
However, only one ST6(N) enzyme, L-galactoside
K2,6-sialyltransferase (ST6Gal I), has been identi¢ed
for synthesis of the SiaK2-6GalL1-4GlcNAc (Sia6-
LacNAc) that is expressed on widely distributed N-
glycans [5].
The complete ST6Gal I cDNA was cloned ¢rst in
rat [6]. The sequence of human ST6Gal I cDNA
corresponds closely to that of the rat [7,8] and the
human gene for this sialyltransferase was mapped to
chromosome 3 (q21-q28) [9]. ST6Gal I mRNA is
widely expressed and levels are high in liver and
hematopoietic cells of certain lineage [10]. The Sia6-
LacNAc product of the ST6Gal I sialyltransferase is
the ligand for the CD22 lectin molecule expressed on
B lymphocytes. Expression of the enzyme and its
Sia6LacNAc product are essential for B lymphocyte
activation and normal immune function [5].
Numerous alterations of cell surface oligosaccha-
rides have been reported in association with neoplas-
tic transformation [11,12]. In human colonic speci-
mens, K2,6-linked residues were expressed in
neoplastic but not normal tissue [13]. We reported
that ST6Gal I mRNA levels were 2-fold greater in
adenocarcinomatous than adjacent normal colonic
tissues [14]. Using a murine monoclonal antibody
to rat ST6Gal I sialyltransferase, reactivity was ab-
sent or very weak in human non-neoplastic colonic
tissue, all adenomas were reactive, and well or mod-
erately well di¡erentiated colonic carcinomas were
more likely to be positive for ST6Gal I protein
than poorly di¡erentiated tumors [15]. In another
survey of surgically obtained tissues, ST6Gal I activ-
ity was increased in cell isolates from specimens of
metastasizing colorectal adenocarcinomas [16].
Evidence from experimental studies that ST6Gal I
expression and its sialoside products may play a
causal role in the progression of colorectal carcinoma
is con£icting. We found that ST6Gal I mRNA levels
and activity were approx. 4-fold greater in murine
colon cancer cells with high liver-colonizing potential
that were resistant to lysis by natural killer (NK)
cells than in variants of the same cell line with low
liver-colonizing potential [17]. In another study, how-
ever, susceptibility to NK lysis was no di¡erent in
transfectants of human colon cancer cells that over-
expressed ST6Gal I than in control cells [18].
Antisense nucleotide sequences have been used
with varying success for speci¢c functional blockade
of gene expression [19] but there are few reports of
the use of this approach for functional studies of
glycosyltransferase expression. ST6Gal I mRNA
and activity were decreased by treatment of colonic
(HT29) cells with speci¢c antisense oligodeoxynu-
cleotides that were complementary to the region of
the start codon of the human ST6Gal I cDNA [20].
Expression of N-acetylgalactosaminyltransferase type
1 in a human gastric cancer cell line, JRST, was
downregulated after transfection with full-length
GalNAc-T1 cDNA in antisense orientation [21]. Pre-
dicted changes in ganglioside expression were
achieved in neuroblastoma cells after stable transfec-
tion with GD3 synthase (a ST8 sialyltransferase)
antisense DNA [22]. Here, we report stable transfec-
tion of human colonic (HT29) cells with ST6Gal I
antisense DNA. ST6Gal mRNA and protein levels
and activity were profoundly decreased in transfected
cells, with corresponding reductions in expression of
K2,6-linked N-glycan product.
2. Materials and methods
2.1. Cell culture
Human colon cancer cell line HT29 and human
hepatoblastoma cell line Hep G2 were purchased
form American Type Culture Collection (Bethesda,
MD). HT29 cells were cultivated in Dulbecco’s
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modi¢ed Eagle’s medium (DMEM; Gibco, Grand
Island, NY) and Hep G2 in equal parts RPMI (Gib-
co) and DMEM. Cultures of both cell lines were
supplemented with 10% heat-inactivated FBS (Sig-
ma, St. Louis, MO), 10 U/ml penicillin and 10 Wg/
ml streptomycin. In addition, Hep G2 cultures were
supplemented with non-essential amino acids and so-
dium pyruvate (110 mg/l). Cultures were maintained
at 37‡C in a humidi¢ed 5% CO2 incubator.
2.2. Construction of antisense vector
Total RNA was isolated as described [14] from
Hep G2 cells for reverse transcription^polymerase
chain reaction (RT^PCR). First strand cDNA was
synthesized using AMV reverse transcriptase and
random primers (Gibco). A 648 base pair segment
of the human ST6Gal I cDNA [7,8] was targeted
using the following primers: 5P, GGACTAGTCCG-
GAGGTGGCAGCGCAGGGC; and 3P, GCTCTA-
GATGCCAGGTGTCCATCCCCGTG. The tar-
geted sequence, from nucleotide (nt) 225 to nt 872
of the full-length cDNA, includes the translation
start site and avoids the conserved sialyl motifs of
ST6Gal I and other sialyltransferases [23,24]. The
forward primer was phosphorylated using T4 poly-
nucleotide kinase (Invitrogen, Carlsbad, CA). PCR
was performed with a Minicycler (MJ Research,
Watertown, MA) for 30 cycles. Each ampli¢cation
cycle included denaturation (94‡C for 1 min), primer
annealing (60‡C, 1 min) and primer extension (72‡C,
1 min). PCR products were analyzed by electropho-
resis on 1.2% agarose gels and visualized by staining
with ethidium bromide.
A 648 bp PCR product, a putative ST6Gal I
cDNA fragment, was ligated in antisense orientation
to pCR3.1-Uni Vector (Invitrogen) by overnight in-
cubation at 14‡C. This vector includes a neomycin/
kanamycin resistance gene. One Shot TOP10FP
Competent cells (Invitrogen) were transformed with
the vector-cDNA product. To con¢rm that the insert
included the intended ST6Gal I antisense cDNA se-
quence, DNA was subjected to restriction mapping
and sequencing.
For transfection, solutions of antisense insert
cDNA or ‘empty’ plasmid vector without ST6Gal I
cDNA (both at cDNA concentrations of 20 Wg/ml)
and lipofectin (Gibco) at a concentration of 20 Wl/ml
were mixed in serum-free DMEM. HT29 cells were
incubated in 60 mm dishes for 24 h with the trans-
fection mixture. Medium was replaced with fresh
DMEM containing 10% FBS for 48 h before further
culture in medium supplemented also with G418
(Gibco) at a concentration of 800 Wg/ml for selection
of antibiotic-resistant strains. Surviving, successfully
transfected HT29 strains were subsequently cultured
in DMEM containing 10% FBS and G418 (400 Wg/
ml). Six strains were derived from di¡erent HT29
cultures over a period of months, each transfected
with the same ST6Gal I antisense cDNA.
2.3. Isolation of RNA and Northern analysis
Isolation of total cellular RNA, gel electrophore-
sis, Northern blotting and hybridization with glyco-
syltransferase cDNAs were performed as described
[14,25]. Hybridizations were performed with ST6Gal
I [7], L1,4-galactosyltransferase (GalT) and N-acetyl-
glucosaminyltransferase I (GlcNAcT I) cDNAs.
GalT and GlcNAcT I, respectively, were gifts from
Drs. M. Fukuda [26] and H. Schachter [27]. North-
ern blots were hybridized with L-actin (Oncor, Gai-
thersburg, MD) as well as glycosyltransferase
cDNAs to con¢rm that equivalent amounts of total
RNA had been loaded in each lane of a gel.
2.4. Western blotting and analysis
HT29 cell membrane proteins were prepared as
described [28]. Brie£y, lysates were electrophoresed
on polyacrylamide gels in the presence of sodium
dodecyl sulfate (SDS^PAGE) and electroblotted to
an Immobilon-P membrane (Millipore, Bedford,
MA). The membrane was incubated for 4 h in phos-
phate-bu¡ered saline (PBS) containing 10% non-fat
milk and 0.1% Tween at pH 7.4. This was followed
by overnight incubation at room temperature with
rabbit anti-rat ST6Gal I antibody (a gift from Dr.
K.J. Colley, University of Illinois, Chicago, IL) di-
luted 1/1000 in PBS containing 10% non-fat milk and
0.1% Tween at pH 7.4. The membrane was washed
three times with PBS containing 0.1% Tween at pH
7.4, incubated with horseradish peroxidase-conju-
gated goat anti-rabbit IgG (Sigma) for 1 h at room
temperature, and washed four times with PBS con-
taining 0.1% Tween at pH 7.4. It was then incubated
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with chemiluminescent detection reagents (ECL
Western blotting detection reagents, KPL, Gaithers-
burg, MD) according to the manufacturer’s instruc-
tions and exposed to X-ray ¢lm.
2.5. Sialyltransferase assay
Speci¢c L-galactoside K2,6-sialyltransferase activ-
ity of whole-cell homogenates was assayed as de-
scribed [25,28] with modi¢cations [29]. Activity of
the supernatant obtained after centrifugation of ho-
mogenate was assayed using CMP-N-acetyl[4,5,6,
7,8,9-14C]neuraminic acid (CMP-[14C]NeuAc) as do-
nor and asialo-K1-acid glycoprotein (asialo-AGP) as
acceptor. Radioactivity of the reaction product was
measured by liquid scintillation spectrometry. The
protein content of cellular homogenates was quanti-
tated by the method of Bradford [30]. Speci¢c sialyl-
transferase activities of parental and ST6Gal I anti-
sense DNA-transfected HT29 cells were compared by
two-tail t-test.
2.6. Cell viability
Parental, ST6Gal I antisense DNA-transfected, or
empty vector-transfected cells were labeled with
[3H]leucine (5 WCi/ml) for 2 h. The cells were har-
vested and precipitated with 20% trichloroacetic acid
at 4‡C. The precipitate was pelleted by centrifugation
and resuspended in 2 ml of 0.2 N NaOH, and an
aliquot was counted for radioactivity. Incorporation
was normalized to protein content.
2.7. Fluorescent lectin analysis of sialylated membrane
proteins
Parental, ST6Gal I antisense DNA-, or empty vec-
tor-transfected HT29 cells were harvested using
0.125% trypsin, washed in PBS and passed several
times through a 22-gauge needle to produce single
cell suspensions. Cell suspensions were incubated
with £uorescein isothiocyanate (FITC)-Sambucus ni-
gra (SNA), Maackia amurensis (MAA) or Erythrina
cristagalli (ECA) lectin (EY Laboratories, San Ma-
teo, CA) at a concentration of 50 Wg/ml for 1 h at
room temperature and washed three times in PBS.
Cell suspensions in PBS without FITC-lectin were
used as controls. Aliquots of 5000 cells in suspension
were subjected to analysis using a FACS cytometer
(Becton Dickinson, Mountain View, CA). Non-via-
ble cells, identi¢ed by staining red with ethidium
bromide (1 Wg/ml), were excluded from analysis.
2.8. Puri¢cation, thin layer chromatography (TLC)
and quantitation of HT29 gangliosides
The ganglioside fraction of parental, ST6Gal I
antisense DNA-, or empty vector-transfected HT29
cultures was isolated and processed as described [31].
Brie£y, cellular lipid fractions were extracted in
chloroform:methanol (1:1). Combined extracts and
rinses from each preparation were dried by rotary
evaporation. Gangliosides were puri¢ed from cellular
lipid extracts by serial chromatographic elutions. The
total ganglioside fraction was dried by rotary evap-
oration and prepared for examination by two-dimen-
sional development on high performance TLC
(HPTLC) plates (E. Merck, Darmstadt, Germany).
Gangliosides containing 4^6 Wg of sialic acid were
spotted for each TLC plate and standard markers
of murine brain gangliosides were run in each dimen-
sion for reference. After development and drying,
gangliosides were visualized with resorcinol reagent.
Chromatograms of gangliosides from matched prep-
arations of parental and ST6Gal I antisense DNA-
transfected HT29 cultures were puri¢ed and devel-
oped at the same time.
Densitometric analysis of chromatograms was per-
formed with a two-dimensional scanner (Molecular
Dynamics, Sunnyvale, CA) as previously described
[31]. It is not possible to place precisely identical
quantities of puri¢ed gangliosides on each TLC.
Slight di¡erences in the absolute quantities of gan-
gliosides spotted could have made conclusions in-
ferred from direct comparison of matched peaks mis-
leading. Therefore, the densitometric intensity of
each peak was expressed as a percentage of the total
amount of ganglioside on a chromatogram. Quanti-
tative comparisons were between corresponding
peaks, expressed as percentages, on paired chromato-
grams. Discrimination between individual peaks re-
quired visualization of a distinct division between
peaks whose measurements were within one standard
deviation of background values. Analyses of stan-
dard ganglioside preparations of known quantities
indicate that error in assigning relative percentages
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becomes progressively greater for lower intensity
spots. Therefore, values of 6 0.5% of the total
were designated ‘trace’. Findings were reproduced
in separate experiments. Statistical signi¢cance be-
tween relative intensities of matched peaks was de-
termined by two-tail t-test.
2.9. Cell aggregation assay
Aggregation of parental, antisense DNA- or empty
vector-transfected cells was assessed as described
[32]. Cells (1U104 cells/well) were incubated for 15
min in Ca2- and Mg2-free PBS at 4‡C in 24-well
plates. After incubation, plates were examined micro-
scopically for aggregates, de¢ned as clumps of v 4
cells. Three hundred cells were counted in each well.
The assay was performed in six wells for each HT29
variant.
2.10. Anchorage-independent growth assay
Colony-forming ability of parental, antisense
DNA- or empty vector-transfected HT29 cells in
soft agarose was assessed as described [33]. Brie£y,
a 1 ml single cell suspension (3U103 cells) in 0.8%
agarose was added to an already hardened bottom
layer of 0.8% agarose in 35 mm tissue culture dishes.
Dishes were incubated in a 5% CO2 atmosphere at
37‡C. After 14 days, colonies measuring s 100 Wm
were counted under an inverted microscope. Values
for colony-forming ability were derived from results
of four separate experiments with each cell type. Dif-
ferences in the numbers of colonies formed by anti-
sense DNA-transfected or control cells were com-
pared for signi¢cance by two-tail t-test.
2.11. Cell invasiveness
Invasive ability of parental and antisense-trans-
fected HT29 cells was compared using Biocoat Ma-
trigel chambers (Becton Dickinson, Bedford, MA)
that comprise two compartments separated by a
membrane of 8 Wm pore size [33,34]. Medium (0.25
ml) was added to the chambers, placed in culture
plate wells, and the culture plates were incubated at
37‡C for 2 h to rehydrate Matrigel-coated chamber
inserts. The rehydrating medium was carefully re-
moved. HT29 suspensions were prepared at a con-
centration of 1U106 cells/ml in medium constituted
as already described. Conditioned medium (0.75 ml)
from NIH 3T3 cell cultures was added to empty
culture plate wells to serve as a chemoattractant so-
lution. Chambers with Matrigel-coated or uncoated
(control) inserts were placed in wells containing che-
moattractant solutions. Parental or antisense-trans-
fected HT29 cell suspension (0.5 ml, 5U105 cells)
was placed on top of the inserts. Plates holding the
assembled chambers were incubated at 37‡C in a
humidi¢ed 5% CO2 incubator for 24 h.
After incubation, residual non-invading cells were
gently wiped from the top surface of inserts. Protocol
Hema 3 stain (Biochemical Sciences, Bridgeport, NJ)
was applied to the bottom surface of Matrigel-coated
or uncoated inserts for microscopic visualization of
invading cells. In each of ¢ve Matrigel chamber ex-
periments with fresh parental or antisense-transfected
cultures, the mean number of cells per high power
¢eld (HPF) was calculated from counts of three sep-
arate ¢elds. The number of cells invading Matrigel-
coated inserts as a percentage of the number of the
same variety of cell (parental or antisense-trans-
fected) passing through uncoated membranes was
calculated to give an index of invasiveness. The val-
ues of invasiveness for parental and antisense-trans-
fected cells from the four Matrigel chamber experi-
ments were compared statistically by two-tail t-test.
3. Results
3.1. ST6Gal I mRNA is undetectable in
antisense-transfected HT29 cells
Glycosyltransferase mRNA expression was inves-
tigated by Northern analysis. In the six separately
derived HT29 strains that expressed the antisense
DNA, ST6Gal I mRNA was undetectable, compared
to parental HT29 cells and those transfected with
‘empty’ plasmid vector without ST6Gal I. Results
of Northern analysis of glycosyltransferase mRNA
expression in representative parental, and antisense-
and empty vector-transfected HT29 strains are
shown in Fig. 1.
Terminal N-glycan sialic acids are linked to galac-
tose residues, which are linked in turn to N-acetyl-
glucosamines. N-Acetylglucosamine (GlcNAc) and
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galactose (Gal) sugars, respectively, are transferred
sequentially to oligosaccharide chains by the actions
of GlcNAcT I and GalT enzymes. To investigate the
speci¢city of ST6Gal I sense mRNA silencing in
transfected cells, GlcNAcT and GalT mRNA levels
were assessed in the same Northern blot that was
probed for ST6Gal I mRNA. In contrast to the un-
detectable levels of ST6Gal I mRNA, expression of
GlcNAcT I and GalT mRNA was unaltered in
ST6Gal I antisense DNA-transfected cells.
3.2. ST6Gal I protein is undetectable and ST6Gal
activity is reduced in antisense-transfected
HT29 cells
Expression of enzyme protein was investigated by
Western analysis. ST6Gal I protein was undetectable
in the six separately derived HT29 strains that ex-
pressed the antisense DNA compared to parental
HT29 cells and those transfected with ‘empty’ plas-
mid vector without ST6Gal I. Results of Western
analysis of ST6Gal I protein expression in represen-
tative parental, and antisense- and empty vector-
transfected HT29 strains are shown in Fig. 2.
ST6Gal I protein was undetectable in HT29 trans-
fectants expressing antisense DNA for this enzyme.
A protein of the expected size was readily detectable
Fig. 1. ST6Gal I but not GalT or GlcNAcT mRNA is unde-
tectable in antisense DNA-transfected HT29 cells. Total cellular
RNA was isolated from parental HT29 cells, empty vector
transfectants with no insert (Vector) and ST6Gal I antisense
DNA transfectants (Antisense), electrophoresed and transferred
to membranes as described in Section 2. Blots of the same gel
were hybridized with cDNAs for ST6Gal I, L1,4-galactosyl-
transferase (GalT), L1,2-N-acetylglucosaminyltransferase I
(GlcNAcT) or, for normalization, L-actin.
Fig. 2. ST6Gal I protein is undetectable in antisense DNA-
transfected HT29 cells. Lysates from parental HT29 cells,
empty vector transfectants (Vector) and ST6Gal I antisense
DNA transfectants (Antisense) were electrophoresed and trans-
ferred to membranes that were then incubated with polyclonal
antibody to rat ST6Gal I as described in Section 2. Bound anti-
bodies were detected by chemiluminescence.
Table 1
ST6Gal activity in untransfected and transfected HT29 cells
HT29 variant Speci¢c activity (nmol/mg) protein/h P
Parental 0.022 þ 0.002 6 0.005
Empty vector 0.020 þ 0.002 6 0.005
Antisense 0.003 þ 0.001
STGal activity in crude homogenates of parental HT29, HT29 cells transfected with empty vector or HT29 cells transfected with
STGal I antisense DNA was assessed by measurement of transfer of CMP-[14C]NeuAc to exogenous asialo-AGP (see Section 2). Data
are means þ S.E. of the results of three experiments. P values are for comparison of speci¢c activity of that HT29 variant with ST6Gal
I antisense-transfected HT29 cell cultures.
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in lysates of parental and empty vector-transfected
HT29 cell cultures using speci¢c ST6Gal I antibody.
ST6Gal activity was reduced in antisense transfec-
tants compared to parental and empty vector-trans-
fected HT29 cell cultures (Table 1). ST6Gal speci¢c
activity in antisense transfectants was reduced by
86% (P6 0.005) and 85% (P6 0.005), respectively,
compared to parental and empty vector-transfected
HT29 cultures.
3.3. Cell growth and viability are unaltered in
antisense-transfected HT29 cells
Selective loss of ST6Gal I mRNA expression but
not other N-glycan glycosyltransferases in HT29
antisense transfectants suggested speci¢c functional
silencing of the ST6Gal I gene. Consistent with ab-
rogated expression of a single sialyltransferase gene
in the transfected cells without more general altera-
tion of cell behavior, doubling time (approx. 22 h)
and total protein synthesis as assessed by [3H]leucine
incorporation into acid-insoluble material (data not
shown) of parental, antisense-transfected, or empty
vector-transfected HT29 cells did not di¡er signi¢-
cantly.
3.4. Expression of glycoprotein K2,6-linked sialic acid
is decreased in ST6Gal I antisense
DNA-transfected HT29 cells
N-Acetyllactosamine (LacNAc, GalL1-4GlcNAc)
is the oligosaccharide acceptor to which ST6Gal I
transfers sialic acid, thus synthesizing Sia6LacNAc.
LacNAc is the acceptor also for ST3Gal III sialyl-
transferase that synthesizes SiaK2-3GalL1-4GlcNAc
(Sia3LacNAc). Two consequences for N-glycan Lac-
NAc residues can be envisaged in transfected cells
that do not express ST6 Gal I. Sia3LacNAc could
be formed through the action of ST3Gal III or the
6
Fig. 3. ST6Gal I antisense DNA-transfected HT29 cells have al-
tered lectin-binding pro¢les. Cultures of ST6Gal I antisense
transfectant (heavy, solid line), empty vector transfectant
(hatched line) or parental (light, solid line) HT29 cells were pre-
pared as a single-cell suspension and incubated with FITC-SNA
(A), -MAA (B), or -ECA (C) lectins. Aliquots of approx. 5000
cells in suspension were subjected to £ow cytometric analysis.
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LacNAc residues could remain unmasked. The lectin
agglutinins SNA, MAA and ECA, respectively, rec-
ognize exposed K2,6- [35] and K2,3-linked [36] sialic
acids, and LacNAc [37]. Flow cytometry was per-
formed to analyze FITC-SNA, -MAA and -ECA
binding by HT29 cells. Similar plots were obtained
for SNA-labeled parental HT29 cells and empty vec-
tor transfectants (Fig. 3A). Pro¢les of the plots were
broad, with two cell number peaks corresponding to
£uorescence intensity of approx. 102 and 103. The
pro¢le for SNA-labeled ST6Gal I antisense DNA
transfectants was quite distinct, with a single large
peak at a lower value of £uorescence intensity than
the approx. 102 peak of parental HT29 cells and
empty vector transfectants. The £ow cytometric pro-
¢les of antisense DNA-transfected, parental and
empty vector HT29 cells labeled with MAA were
virtually identical (Fig. 3B). Pro¢les of ECA-labeled
parental and empty vector HT29 cells were practi-
cally identical (Fig. 3C). Fluorescence intensity at
the cell number peak for antisense DNA-transfected
cells was substantially greater than for control (pa-
rental and empty vector) HT29 cells.
Table 2
Quantitative comparisons of corresponding ganglioside peaks

















Results are shown of densitometric analysis of thin layer chro-
matograms shown in Fig. 4. Numeric values for ganglioside
peaks on a chromatogram represent absolute measurements ex-
pressed as a percentage of the total ganglioside content on that
chromatogram. Results given are the range for each peak from
two separate experiments. ‘Peak No.’ refers to the correspond-
ing number on the schematic chromatogram in Fig. 4.
Fig. 4. Ganglioside pro¢les of ST6Gal I antisense DNA trans-
fectant and parental HT29 cells are indistinguishable. Ganglio-
sides were extracted from parental (upper panel) or antisense
DNA-transfected (lower panel) HT29 cells and analyzed on
two-dimensional TLC as described in Section 2. A schematic di-
agram of the TLC plates (middle panel) indicates individual
peaks designated by numbers that correspond to those given in
Table 2. All designated ganglioside peaks were resorcinol-posi-
tive; impurities visible on TLCs were resorcinol-negative. A
circle in the right lower corner denotes the origin. Chromato-
graphic positions of murine brain ganglioside standards are giv-
en on the top (¢rst solvent) and left (second solvent) margins.
Ganglioside standards are indicated as GM1-M, GD1a-D, GT1b-T
and these abbreviations conform to the Svennerholm nomencla-
ture [57]. Each TLC contained 4^6 Wg lipid-bound sialic acid.
C
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3.5. Parental and ST6Gal I antisense
DNA-transfected HT29 cells have similar
ganglioside pro¢les
It has been shown that, in addition to elaborating
the Sia6LacNAc structure on N-glycan oligosaccha-
rides, ST6Gal I can transfer sialic acid to glycolipids
in vitro [38,39]. To investigate the possibility of this
function in colonic cells, the ganglioside pro¢les of
parental and ST6Gal I antisense DNA-transfected
HT29 cultures were compared (Fig. 4 and Table 2).
Nine discrete resorcinol-positive peaks were visible
on TLCs of each group. Although some ganglioside
peaks (peaks 1 and 2) appear as overlapping dou-
blets, densitometric analysis permitted reasonable de-
lineation of borders. Therefore, these doublets were
designated as solitary peaks.
There were only minor di¡erences between the
pro¢les and relative intensities of individual peaks
in the ganglioside chromatograms of parental and
antisense-transfected HT29 cells. No peaks that
were present in chromatograms of parental cell gan-
gliosides were absent from ganglioside pro¢les of
antisense-transfected cells. Slight variations were
seen in the relative intensities of some minor peaks.
Ganglioside pro¢les of empty vector-transfected cells
were indistinguishable from those of parental cells
(data not shown).
3.6. In vitro aggregation of HT29 variants
The ability to form aggregates was similar in pa-
rental, antisense DNA- and empty vector-transfected
HT29 cells. The number of aggregates was approx.
6^8/300 cells counted for each variant.
3.7. Anchorage-independent growth of antisense
DNA-transfected cells is reduced
Anchorage-independent growth in vitro is an index
of the potential aggressiveness of neoplastic cells and
can distinguish cell lines with similar capability for
monolayer growth [33]. The ability to form colonies
when grown in soft agarose for 14 days was virtually
abolished (reduced by approx. 98%, P6 0.0001) in
antisense DNA-transfected cells (Table 3). In con-
trast, the colony-forming ability of parental and
empty vector-transfected cells was robust.
Table 4
Invasiveness in vitro of untransfected and transfected HT29 cells
HT29 variant Matrigel-coated inserts (cells/HPF) Uncoated inserts (cells/HPF) Invasiveness (%) P
Parental 65 þ 15 115 þ 30 62 þ 7
Antisense DNA 20 þ 4 106 þ 16 19 þ 2 6 0.005
The ability was assessed of parental HT29 cells and HT29 cells transfected with ST6Gal I antisense DNA to invade Matrigel-coated
and uncoated membranes in two-compartment Biocoat chambers. Cells were placed in the upper compartment, separated from the
lower chamber by a coated or uncoated membrane. Conditioned (chemoattractant) medium from NIH 3T3 cells was placed in the
lower compartment and cells were incubated at 37‡C for 24 h. Membrane inserts were removed, stained with Protocol Hema 3 and
examined under a microscope. In four separate experiments, the average number of cells in three high power ¢elds that had invaded
through coated or uncoated membranes was determined. The number of cells invading Matrigel-coated membranes in each experiment
was expressed as a percentage of cells passing through uncoated inserts to represent the invasiveness of parental or antisense DNA-
transfected cells. Values given are means þ S.E. from the four experiments. The P value is for comparison, by two-tail t-test, of anti-
sense-transfected and parental HT29 cells.
Table 3
Anchorage-independent growth in vitro of untransfected and
transfected HT29 cells
HT29 variant Colonies/35 mm dish P
Parental 322 þ 8
Empty vector 316 þ 13
Antisense DNA 7 þ 1 6 0.0001
The ability was assessed of parental HT29 cells, and cells trans-
fected with ST6Gal I antisense DNA or empty vector to form
colonies when grown in soft agarose [32]. A single cell suspen-
sion in 0.8% agarose was added to a bottom layer of agarose
in 35 mm dishes. After incubation for 14 days at 37‡C, colonies
measuring s 100 Wm were counted under an inverted micro-
scope. Determinations were performed in triplicate. Values giv-
en are the mean numbers of colonies þ S.E. The P value is for
comparison by two-tail t-test of the numbers of colonies formed
by parental or empty vector-transfected HT29 cells with colo-
nies of antisense DNA-transfected cells.
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3.8. Reduced invasiveness of antisense
DNA-transfected HT29 cells in Matrigel
chambers compared to parental cells
The ability of antisense-transfected and parental
cells to penetrate extracellular matrix material (Ma-
trigel) in vitro was assessed to determine whether
silencing the ST6Gal I gene reduces the invasive abil-
ity of cells. Invasiveness of transfected and parental
cells is shown in Table 4. The invasiveness of trans-
fectants (19%) was reduced more than 3-fold com-
pared to parental HT29 cells (62%, P6 0.005).
4. Discussion
We reported previously profound downregulation
of human ST6Gal I expression in vitro by agents of
potential relevance in vivo. Agents with this property
included butyrate [25], a secondary but not a primary
bile acid and a phorbol ester [29]. Although relative
speci¢city and the intracellular pathway for sialyl-
transferase gene regulation could be demonstrated
in each case, with this approach it is impossible to
distinguish the functional e¡ects of sialyltransferase
expression from those of numerous other genes that
can be regulated by such agents. A model character-
ized by selective blockade of ST6Gal I expression
could provide the means for more de¢nitive function-
al studies.
The sialoside Sia6LacNAc product of ST6Gal I is
the ligand for the B lymphocyte CD22 antigen
[40,41]. To investigate the role of murine ST6Gal I,
the gene was targeted for systemic mutation [5]. The
resulting ST6Gal I-de¢cient mice were viable but ex-
hibited hallmarks of severe immunosuppression, con-
sistent with the conclusion that the Sia6LacNAc ol-
igosaccharide of ST6Gal I is essential in promoting B
lymphocyte activation and immune function. From
their exposed extracellular position, oligosaccharides
such as Sia6LacNAc are well suited for a role in
homotypic and heterotypic cell^cell interactions. It
has been widely speculated that, by virtue of the
terminal position and negative charge of the sialic
acid molecule, excessive or misplaced cellular sialyla-
tion could subvert normal cell^cell recognition pro-
cesses and enhance invasion and metastasis by ma-
lignant cells. In the present study, our purpose was
to generate stable antisense transfectants of human
colon cancer HT29 cells in which the ST6Gal I gene
is functionally silenced, and to characterize sialic
acid-bearing glycoconjugates in these cells to ascer-
tain speci¢city of gene silencing.
The combination of undetectable levels of ST6Gal
I mRNA and protein, and fully preserved GlcNAcT
and GalT expression in the antisense-transfected cells
suggests a precise disruption of the glycosylating ap-
paratus through silencing of a single gene, ST6Gal I.
The reproducibility of this e¡ect in six separately
derived HT29 strains transfected with the same
ST6Gal I antisense DNA construct indicates the
near certainty that blockade of ST6Gal I expression
was responsible for altered behavior of the trans-
fected strains, rather than unrelated artifacts of clo-
nal variation. Less than perfect speci¢city of the ST6
Gal I enzyme assay, manifesting as measurable
ST3(N) activity, probably accounts for modest
(14%) residual ST6Gal enzyme activity in antisense-
transfected cells.
Critical to evaluating the e¡ectiveness of an anti-
sense DNA strategy is the demonstration that altered
expression of a targeted enzyme’s products has oc-
curred to an extent consistent with reduced expres-
sion of that enzyme. Selected lectins can be highly
speci¢c probes for detecting oligosaccharide product
[39,42]. The £ow cytometric pro¢le of antisense-
transfected cells incubated with SNA, distinct from
the pro¢les of control cells, indicates pronounced
reduction of cell membrane terminal K2,6-linked
sialic acids in the transfected cells. Expression of
O-glycan oligosaccharides, such as the sialyl-Tn epi-
tope, terminating in K2,6-linked sialic acids that are
not transferred by ST6Gal I may account for resid-
ual SNA binding by these cells [43]. The possible
fates of unmasked N-glycan LacNAc (GalL1-
4GlcNAc) oligosaccharides in cells not expressing
ST6Gal I include the following two alternatives. Lac-
NAc residues that would otherwise accept K2,6-
linked sialic acids could accept sialic acids in K2,3-
linkage. Alternatively, the terminal galactoses of the
LacNAc residues might remain unmasked. The ¢nd-
ing of identical MAA-binding pro¢les of antisense
DNA-transfected and control cells argues against
the ¢rst outcome. The distinct, more intense ECA-
binding pro¢le of the transfected cells indicates un-
equivocally an excess of unmasked LacNAc residues
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in the transfected cells. Taken together, the lectin-
binding data demonstrate clearly a disruption of N-
glycan K2,6-sialoside synthesis and consequent un-
masking of LacNAc glycans in HT29 cells expressing
ST6Gal I antisense DNA.
From product analysis [39] and in vitro synthesis
utilizing glycolipid acceptors [38], it is evident that
ST6Gal I can transfer sialic acids in K2,6-linkage to
glycolipid as well as glycoprotein acceptors. In the
present study, however, this was not the case since
ganglioside pro¢les of parental and ST6Gal I anti-
sense DNA-transfected cells were substantially simi-
lar. All gangliosides that were discernible in parental
cell extracts could be identi¢ed on ganglioside pro-
¢les of antisense transfectants. The lack of interfer-
ence with ganglioside synthesis is further evidence of
the selectivity with which this antisense construct si-
lenced expression of a single sialyltransferase.
Although increased ST6Gal I expression has been
reported in association with the progression and
metastasis of colorectal neoplasms [13^17], evidence
of a causal role for the enzyme in this context has
been elusive. We assessed homotypic cell^cell aggre-
gation by only one, relatively crude method; similar
aggregate-forming abilities of parental, antisense
DNA- and empty vector-transfected cells in the
present study should not, therefore, be taken as de-
¢nitive evidence that ST6Gal I expression does not
in£uence homotypic cellular aggregation. However,
the near-complete inability of ST6Gal I antisense
DNA-transfected cells to form colonies in soft aga-
rose and the substantial reduction in the ability of
these cells to invade Matrigel-coated membranes in
the present in vitro study suggest that expression of
this enzyme could contribute causally to the ability
of colorectal cancer cells to invade and metastasize in
vivo.
Three broad mechanisms can be envisaged where-
by alterations to exposed N-glycans of cells in which
ST6Gal I expression has been abrogated could inhib-
it their invasive and metastatic potential. First, cell^
cell and cell^matrix interactions could be in£uenced
non-speci¢cally by reduced surface net negative
charge of cells in which sialyltransferase expression
has been inhibited. In the present study, expression
of N-glycans bearing K2,3-linked sialic acids was
fully preserved and it seems unlikely that reductions
in the net negative charge of transfected cells alone
could have accounted for their altered behavior in
vitro. Second, speci¢c cell^cell or cell^matrix interac-
tions of exposed LacNAc structures with galectins
[44^46] and other macromolecules may anchor nor-
mal cells. These LacNAC structures might be
masked by K2,6-linked sialic acids in cancer cells,
thus permitting them to invade and metastasize.
Third, N-glycans bearing terminal K2,6-linked sialic
acids may contribute directly to invasion and meta-
stasis through speci¢c cell^cell or cell^matrix interac-
tions that do not occur in their absence.
The multiple steps of the metastatic cascade have
been well characterized and are thought to be similar
in all tumors [47]. Initially, carcinoma cells must
weaken cell and extracellular matrix (ECM) adhesive
interactions in order to free themselves from the pri-
mary tumor but at subsequent stages of the meta-
static process, strengthening of cell and matrix inter-
actions may be advantageous. Assays of anchorage-
independent growth and invasion of Matrigel-coated
membranes, as in the present study, focus on the
early stages of the metastatic cascade. A variety of
cell surface receptors mediate the cell^cell and cell^
substratum interactions that stabilize tissue structure
under physiological conditions and disrupt normal
architecture in the context of invasion. Adhesion-re-
lated transmembrane glycoprotein receptor mole-
cules are distinguishable structurally as separate
groups that include the cadherins, integrins, CD44
and the cell adhesion molecule (CAM) family [48].
The molecules in all these families bear sialylated N-
glycans, which could, therefore, be structurally and
functionally £awed in neoplastic cells that overex-
press ST6 Gal I.
The epithelial (E)-cadherins are required for the
integrity of normal epithelia and are decorated with
sialylated N-glycans. Reduction or loss of E-cadherin
expression weakens homotypic cell^cell interactions
and enhances the escape of tumor cells from primary
tumors [49]. In a study of cell isolates prepared from
surgically resected human colorectal adenocarcino-
mas, non-aggregating cells were distinguished from
aggregating cells by increased ST6Gal I activity and
loss of E-cadherin reactivity [16]. However, in anoth-
er study, enhanced tumor cell invasiveness resulting
from lost or defective expression of E-cadherins was
independent of cadherin N-glycan sialylation status
[50].
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Causal relationships to the metastatic cascade have
been emphatically attributed to changes in integrin
[51], CD44 [52] and carcinoembryonic antigen-re-
lated (C-)-CAM [53] structure. Altered patterns of
N-glycan sialylation have, in turn, been demon-
strated for metastasis-associated variants from each
of these adhesion molecule families [53^55].
Among other ways in which sialylation status of
membrane N-glycans might in£uence invasion and
metastasis is the intriguing possibility of an impor-
tant role in determining cell susceptibility to apopto-
sis. Engagement of the cell surface CD95 sialoglyco-
protein is a key step in the signaling pathway that
drives sensitive cells towards apoptosis. CD95-medi-
ated apoptosis was dramatically enhanced in variants
of a human B lymphoma cell line in which K2,6-
linked sialylation of this receptor was profoundly
reduced in comparison with the sialylation status of
CD95 in variants that were resistant to apoptosis-
inducing signals [56].
In conclusion, we have developed stable transfec-
tants of human colon cancer HT29 cells in which
expression of the ST6Gal I gene is silenced with func-
tional consequences. We believe that this will be a
useful model for further study of the sialylated prod-
ucts of this enzyme and other glycans that may ad-
vance or inhibit the processes of invasion and meta-
stasis.
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